World ADC 2023 – N-Myristoyltransferase (NMT) inhibitors as completely novel payloads for Antibody Drug Conjugates, deliver extensive tumor regression at well tolerated doses.
AACR 2023 – N-Myristolytransferase (NMT) inhibitors as novel potent payloads for antibody drug conjugates
